Home About us Services Blog Contact us

NSE India Limited Unlisted Shares ₹ 2000.00  (170.27%)

Boat Unlisted Shares Price ₹ 1500.00  (17.65%)

Apollo Green Energy Limited Unlisted Shares ₹ 85.00  (-81.11%)

Cochin International Airport Limited Unlisted Shares ₹ 533.50  (154.05%)

Big Basket Unlisted Shares ₹ 1950.00  (2.63%)

ORAVEL STAYS LIMITED (Oyo Unlisted Shares) ₹ 51.00  (-63.57%)

Onix Renewable Limited Unlisted Shares ₹ 150.00  (-34%)

CSK Unlisted Shares ₹ 188.00  (1.62%)

Sterlite Electric Limited (formerly Sterlite Power) Unlisted Shares ₹ 540.00  (-32.5%)

Zepto unlisted shares ₹ 2750.00  (0%)

Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price Price

Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price

72

₹ 155.00 (0) (0%) 5Y

Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price

₹ 155.00

Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price

*Best In Industry

About Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price

Care Health Insurance (formerly Religare Health Insurance) is one of India’s fastest-growing standalone health insurers (SAHI), offering a comprehensive suite of health protection solutions for individuals, families, corporates, and underserved communities. Established in 2012, the company operates under the umbrella of Religare Enterprises Limited, with major shareholding from REL, Union Bank of India, and Corporation Bank.

Over the years, Care Health Insurance has built a robust reputation in the Indian healthcare and insurance ecosystem through product innovation, strong distribution channels, and a rapidly expanding hospital network.

A) Company Background & Evolution

Originally launched as Religare Health Insurance, the company rebranded as Care Health Insurance to reflect a more customer-centric identity. With a decade of operations, the company has:

  • Established a presence as the 2nd-largest Standalone Health Insurer (SAHI)
  • Ranked the 8th-largest health insurer overall in India
  • Achieved strong retail market positioning as the 4th-largest retail health insurer

The company has grown consistently due to its focus on specialized health insurance solutions, unlike multi-line insurers who offer multiple general insurance products.

B) Product Portfolio

Care Health offers one of the most diverse and innovative product ranges in the Indian health insurance sector:

Retail Plans

  • Health Insurance
  • Critical Illness Coverage
  • Personal Accident
  • Top-Up & Super Top-Up Plans
  • Maternity Insurance
  • International Travel Insurance

Corporate Plans

  • Group Health Insurance
  • Group Personal Accident Coverage
  • Customized Corporate Wellness Solutions

The company regularly launches new products designed for evolving healthcare needs, including Care Shield, Arogya Sanjeevani, and various COVID-related protection plans.

C) Strong Market Positioning (FY18–FY23 Growth)

Care Health Insurance has shown remarkable market expansion over five years:

  • Overall Health Market Share: ↑ from 2.5% to 5.3%
  • Retail Health Market Share: ↑ from 4% to 7.7%
  • Group Health Market Share: ↑ from 1.7% to 4.3%

Premium CAGR (FY18–FY23):

  • Overall Premiums: 36%
  • Retail Premiums: 35%
  • Group Health: 45%

This demonstrates Care Health’s strong underwriting capability and rising customer trust.

D) Distribution Strength

Care Health’s business is supported by a powerful multi-channel distribution model:

  • Individual Agents: 35% of premiums
  • Corporate Agents: 18%
  • Direct (incl. Online): 13%

Network Infrastructure

  • 248 branches across India
  • 2.51 lakh+ individual agents
  • 149 corporate agents
  • 22,900+ partner hospitals (cashless network)

Such a wide network has strengthened its reach in retail and group insurance segments.

E) Health Insurance Sector Insights (Growth Drivers)

India’s health insurance penetration remains significantly low:

  • Only 4% of people have individual/family floater policies
  • Total coverage (including government schemes): 38%
  • Market expected to grow 4.5× to 7.6×, reaching ₹1.6–2.6 trillion

Standalone Health Insurers (SAHIs) continue to gain dominance due to:

  • Specialized health insurance product offerings
  • Strong agent networks
  • Strategic partnerships with corporate agents & brokers
  • Better claim servicing & underwriting efficiency

SAHIs today hold:

  • 28.1% market share in overall health (FY23)
  • 54% market share in retail health (FY23)

Care Health is expected to remain one of the major beneficiaries of this trend.

F) Business Performance – FY20–21 Highlights

  • GDPI (Gross Domestic Premium Income): ₹2,559 Cr (↑29.5%)
  • PAT: ₹102 Cr (↑55.7%)
  • Solvency Ratio: 2.45× (vs required 1.50×)
  • Product launches: Care Advantage, Corona Kavach, Covid Care, Group Care 360, Care Shield
  • Network Providers: 16,000+
  • Employees: 9,904 permanent staff
  • Agents: ↑ from 1.32 lakh to 1.69 lakh

Care Health also raised ₹337 Cr through preferential allotment and issued 3.32 Cr ESOPs during the year.

G) FY23 Result Analysis – Robust Growth Across Metrics

1. Gross Direct Premium (GWP)

  • FY23: ₹5,141.52 Cr
  • FY22: ₹3,880.91 Cr

2. Net Earned Premium

  • FY23: ₹3,932.04 Cr
  • FY22: ₹2,510.84 Cr

3. Operating Profit

  • FY23: ₹643.72 Cr
  • FY22: ₹282.97 Cr

4. Net Profit

  • FY23: ₹245.84 Cr
  • FY22: ₹11.50 Cr

5. Total Net Worth

  • FY23: ₹1,749.17 Cr
  • FY22: ₹1,289.20 Cr

6. EPS

  • FY23: ₹2.61** (vs ₹0.13 in FY22)**

Care Health delivered significant improvements in profitability, underwriting, and operational performance.

H) 9M FY24 Financial Performance

Particulars (In ₹ Cr)

9MFY24

9MFY23

GWP

4,827

3,646

NEP

4,253

3,257

Premium Earned

3,731

2,730

PBT

210

195

PAT

156

146

EPS

1.6

1.5

The company continues its growth momentum with higher GWP, premium income, and net profitability.

I) Valuation – Care Health vs Star Health

Metric

Care Health

Star Health

Mcap

₹14,000 Cr

₹34,308 Cr

GWP

₹5,141 Cr

₹11,000 Cr

Mcap/GWP

2.74×

3.11×

Care Health appears more reasonably valued on a Mcap-to-GWP basis, suggesting stronger relative value for investors.

Read More

Fundamentals

Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price

₹ 155.00

Per Equity Share

Lot Size

500 Share

52 Week High

₹ 205.00

52 Week Low

₹ 146.00

Depository

NSDL & CDSL

PAN Number

AADCR6281N

ISIN Number

INE119J01011

CIN

U66000DL2007PLC161503

RTA

KFin Technology

Market Cap (in Cr.)

₹ 15100.00

P/E Ratio

97.48

P/B Ratio

6.36

Debt to Equity

-

ROE(%)

6.53

Book Value

24.36

Face Value

10.00

Total Shares

974184460

Financials

P&L Statement

P&L Statement
Record not found!
Financial Ratios
Record not found!

Balance Sheet

Balance Sheet
Record not found!
Liabilities
Record not found!

Cash-Flow Statement

Cash-Flow Statement
Record not found!

Data not found

Ready to Build Wealth with Unlisted Stocks?

We give you the data, insights, and access—you make the profit.

Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price Price
Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares Price Price arrow

Scan to download

Frequently Asked questions

Everything you need to know before you start investing in unlisted shares.

Unlisted shares are stocks of companies that are not yet listed on the stock exchange. These shares are typically offered to private investors or traded on over-the-counter markets. Investing in unlisted shares provides early access to potentially high-growth companies before they go public.

To invest, simply create an account on Unlisted Radar, browse the available unlisted share listings, and review the detailed company reports. Once you find the right opportunity, you can make an investment through our platform, and we’ll guide you through the process.

We rigorously vet each company based on factors like market potential, financial health, industry trends, and growth projections. Our team conducts deep-dive research, valuation analysis, and performance forecasting to ensure only the most promising companies make it onto our platform.

While unlisted shares offer the potential for high returns, they also come with higher risks compared to traditional investments. Factors such as company performance, market conditions, and regulatory changes can impact the success of your investment. We provide detailed reports to help you assess the risk before investing.

Yes! Through Unlisted Radar, you get access to real-time data, allowing you to track and make decisions about buying or selling shares. However, liquidity can vary based on the company and market conditions, so we always recommend reviewing the market status before making decisions.

We feature companies from a variety of sectors, including technology, healthcare, consumer goods, and more. These companies are typically in their growth phase, with strong potential to go public in the future, providing early investment opportunities.

The minimum investment amount varies by company and listing. Each opportunity will specify the required minimum investment, giving you flexibility depending on your budget and investment goals.

Yes! Unlisted Radar is open to investors worldwide. However, specific regulations and processes may vary depending on your country of residence. Please contact our support team for more details on international investing.

New investment opportunities are listed regularly as we discover high-potential companies. Our team works hard to bring you fresh opportunities, so check back frequently or sign up for our notifications to stay informed about the latest listings.

While we focus on companies with high growth potential, there is no guarantee that any company will go public. If a company doesn’t go public, your investment’s value may still increase depending on the company’s growth, profitability, and other factors. We advise thorough research and understanding of each investment’s risks.

We believe in transparency. Any fees associated with investing are clearly outlined during the investment process. We do not have hidden charges—our goal is to ensure you know exactly what you’re paying for before you make any investments.

We prioritize security and privacy. Unlisted Radar uses industry-leading encryption technologies to protect your personal and financial information. We comply with all necessary data protection laws to ensure your data is safe at all times.

Yes! Our team of experts is available to answer any questions and guide you through your investment journey. Whether you need help understanding reports, valuation metrics, or specific company details, we’re here to support you every step of the way.

If the company you’ve invested in gets acquired, the value of your investment will depend on the terms of the acquisition. You’ll typically receive a payout based on the acquisition deal, which could be in the form of cash or shares in the acquiring company. Our team will keep you updated on any significant events like acquisitions or mergers.

Yes! You can diversify your portfolio by investing in multiple unlisted shares available on our platform. This approach can help spread your risk while potentially increasing your return opportunities.

The withdrawal process depends on the liquidity of the unlisted shares you’ve invested in. Once the shares become tradable or the company undergoes an IPO, you can sell your shares and withdraw your funds. Specific withdrawal instructions will be provided at the time of the investment.

Yes, if the company goes public through an IPO, your unlisted shares become listed shares and can be traded on the stock exchange after the lock-in period, if applicable.

Some of the most talked-about unlisted companies include:
  • 1. Reliance Retail
  • 2. HDFC Securities
  • 3. NSE (National Stock Exchange)
  • 4. Paytm Money
  • 5. Tata Technologies (Availability may vary—verify before investing.)

Unlisted Radar connects investors with India’s most promising unlisted companies through a simple and secure platform.

Quick Links

SEBI Guidelines Disclaimer Privacy Policy

Contact Info

email info@unlistedradar.com

Unlisted Radar © 2025 | All rights reserved